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From the Nuffield Department ofSurgery, University of Oxford,John RadcliffeHospital,
Oxford OX39DU United Kingdom
In recent years, there has been much interest in the cellular events that
accompany tissue graft rejection. It has become clear from the work of Loveland
et al. (1), Dallman et al. (2), and from many subsequent studies (see reference 3)
that the Th cell normally plays a pivotal role in the induction of the rejection
response. However, the relative roles of cytotoxic cells, delayed-type hypersen-
sitivity reactions, and other effector mechanisms in graft destruction still remains
a controversial issue.
The elegant studies of Tyler et al. (4) have shown that a cloned population of
MHC class I-restricted cytotoxic T cells can reject a skin graft through an
epidermal antigen disparity. Similarly, cloned cytolytic T lymphocytes can de-
stroy tumor cell grafts in mice (5). Other workers have shown that an absence of
cytotoxic T cells within a renal graft correlates with graft acceptance (6, 7) and
that depletion of Ly-2' cells in vivo, by the use of mAbs, may lead to prolonged
mouse skin allograft survival (8, 9). On the other hand, using H-Y disparate skin
thereare certain mouse strainsin which graft rejection mayoccur in theapparent
absence of H-Y antigen-specific cytotoxic cells and where delayed-type hyper-
sensitivity correlates well with graft rejection (10). These and many other studies
(see reference 3) seem to demonstrate that in different situations a variety of
effector mechanisms may be called into play in the rejection process. However,
in previous studies (6, 7), the presence of specific cytotoxic cells within a graft
has always correlated with tissue rejection and such cells have not been found in
a graft that survives indefinitely in the absence of any subsequent immuno-
suppression.
Preoperative donor-specific blood transfusion may lead to indefinite survival
ofrat renal allografts (11). In this study, we have extracted cells from the kidney
transplants of animals that have received a donor-specific blood transfusion
preoperativelyand that will retain their grafts indefinitely. Thecytotoxic capacity
ofthese cells has been compared with the activity ofcells isolated from rejecting
grafts. Using this system, we provide direct evidence that a high level of graft-
specific T cell-mediated cytotoxic activity may be present within a tissue that is
not rejected.
This work was supportedby the Medical Research Council, United Kingdom; The National Kidney
research fund, United Kingdom; andthe Nuffield Medicalresearch fund. M. J. Dallmanis a Nuffield
Medical research fellow.
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Materials and Methods
Animals . Lewis-RT1' (LEW), blood group D-Agouti-RTI' (DA), and PVG-RT1`
(PVG) rats were obtained from Harlan-Olac UK Ltd . (Bicester, United Kingdom) or bred
in the animal facility at the John Radcliffe Hospital, Oxford, United Kingdom .
Blood Transfusion .
￿
A donor-specific blood transfusion given intravenously 7 d before
transplantation leads to indefinite survival of a subsequent renal allograft in all strain
combinations used . The following transfusions were used : In theLEW to DA combination,
0.5 ml LEW blood ; in the LEW to PVG combination, 1 .0 ml LEW blood ; in the DA to
PVG combination, 1 .0 ml DA blood . The mean survival time of untreated rats was 10 d
and of blood-transfused rats >100 days in all combinations .
Renal Transplantation . Kidneys were transplanted into the left orthotopic site as
described previously (12) . For survival data, contralateral nephrectomy was carried out 7
d after transplantation .
Preparation of Cell Suspensions .
￿
Kidneys were removed 5 d after transplantation and
infiltrating cells were released by collagenase digestion of the tissue . Kidneys were minced
finely and then incubated for 30 min at 37°C in 5% C02 in RPMI 1640 (041-1875, Gibco
Ltd ., Paisley, United Kingdom) containing 1 mg/ml collagenase (C-2139 ; Sigma Chemical
Co ., Poole, United Kingdom) . The digest was then pressed through a wire mesh and
viable cells were obtained by centrifugation for 20 min, 800 g, 20°C on a single-step
Ficoll gradient (Histopaque 1083-1, Sigma Chemical Co .) . Cells were washed three times
in a prewarmed solution of Dulbecco's A + B solution (BR14a + SR39, Oxoid Ltd .,
Baisingstoke, United Kingdom) containing 2% FCS (DAB/FCS), resuspended at 5 X 106
cells/ml in RPMI 1640 containing 10% FCS, 2.5 X 10-5 M 2-ME, 2 MM L-glutamine,
penicillin, streptomycin, and gentamycin (RPMI complete) . Serial twofold dilutions of the
cell suspension were made and the cells were used immediately as effectors in the "Cr-
release assay .
5 'Cr-release Assay.
￿
A conventional "Cr-release assay (13) was setup using Con A (C-
2631, Sigma Chemical Co.)-activated lymph node cells as targets (Con A blasts) . These
were prepared by incubation of fresh lymph node cell suspensions in RPMI complete
containing 10 jug/ml Con A for 24-48 h at 37 0C in 5% C02 . Targets were harvested,
washed in RPMI 1640 once, and labeled with 300 uCi "Cr (CJS.4 ; Amersham Interna-
tional, Amersham, United Kingdom) for 90 min at 37 °C in 5% C02 . Targets were then
washed four times in DAB/FCS and added to 96-V-well microtiter plates (76-021-05 ;
Flow Laboratories, Rickmansworth, United Kingdom) using 5 X 105 cells/well . Effector
cells were added at an initial E/T ratio of 100:1 to make a total volume of 200 ul/well .
Plates were then centrifuged for 1 min at 400 g and incubated for 6 h at 37 °C in 5%
C02 . 133 A.1 supernatant was then removed for counting . All assays were carried out in
duplicate . Percent specific release was calculated by the formula : % specific release =
[(experimental release-spontaneous release) X 1001/[(maximum release-spontaneous re-
lease)] . Maximum release was calculated as the total counts added in the target cells .
Spontaneous release was never >15% of maximum release .
Results
Cytotoxic Activity in Renal Allografts .
￿
The magnitude of cytotoxic activityfound
in the renal transplants of transfused animals was compared with that found in
similar grafts of untreated controls . Transfused animals were given an intrave-
nous injection of allogeneic blood 7 d before a renal allograft, the blood and
kidney always being from the same donor rat strain . Untreated animals only
received a kidney allograft . 5 d after transplantation, the grafts were removed,
and the infiltrating cells were harvested and used as effector cells in a "Cr-
release assay to measure their cytotoxic activity . As may be seen, in all strain
combinations tested, a high level of cytotoxicity was exhibited by cells infiltrating
the renal allografts of both transfused and untreated animals (Fig . 1) . In the DA568
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FIGURE 1 . Cytotoxicity in renal allografts 5 days after transplantation . Rats were given a
blood transfusion 7 d before receivinga renal allograft . Theblood and kidney were from the
same donor rat strain . Untreated controls were given a renal transplant only . 5 d after
transplantation, the grafted kidneys were removed and the infiltrating cells were harvested
after collagenase digestion of the tissue . These cells were used as effectors in a 6-h 5 'Cr-release
assay against Con A blast targets. Assays are shown for (a) the DA to PVG, (b) the LEW to
PVG, and (c) theLEW to DA strain combinations. In each case, the activity of infiltrating cells
was assayed against targets expressing the alloantigens of the kidney donor strain . All E/T
ratios were performed in duplicate within an assay. The activity of cells from transfused (0)
and untreated (A) rats was compared in the same assay. The results shown are from single
experiments in the three strain combinations tested . Similar results were obtained in 15, 3,
and2other experiments in theLEW to DA, LEWto PVG, andDA to PVG strain combinations,
respectively .
to PVG and LEW to PVG strain combinations, the level of Cytotoxicity in
transfused animals equalled or exceeded that seen in the untreated controls . A
full kinetic analysis of Cytotoxicity has demonstrated that, in transfused animals,
an accelerated infiltration of the graft by cytotoxic T cells occurs . Further, a
significant level of cytotoxic activity may be demonstrated in such grafts until at
least 21 d after transplantation . This will be reported in detail elsewhere (Dall-
man, M. J., K. J. Wood, and P. J . Morris, manuscript in preparation) . It is
important to note that these assays were performed using cells immediately after
extraction from the transplanted kidney and therefore are representative of
effector activity present within the grafts .
Specificity of Cytotoxicity .
￿
To determine the specificity of the cytotoxic activity
within the transplants, "Cr-release assays were always performed using three
different target cells expressing the alloantigens of. (a) blood and kidney donor
type, (b) recipient type, or (c) third-party type . As may be seen from Fig. 2, the
cytotoxic cells obtained from either transfused or untreated animals demon-
strated specificity for kidney donor alloantigens . Results are shown for the LEW
to DA strain combination, but an equal degree of specificity was observed using
both the LEW to PVGand DA to PVG strain combinations . Such Cytotoxicity is
mediated by T lymphocytes since all of the activity resides within the MRC
OX 19+ (rat CD5) cell fraction . This has been demonstrated by separation of
cells on the cytofluorograf and will be reported in detail elsewhere (manuscript
in preparation) . Briefly, however, in the DA to PVG strain combination, MRC
OX19+ cells (99.3% MRC OX19+) showed 23% donor-specific Cytotoxicity and25
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Specificity of cytotoxic activity . DA animalswere given an intravenous injection
of 4.5 ml LEW blood or were not treated, and 7 d later they were transplanted with a LEW
kidney . 5 d after receiving the kidney graft, the transplants were removed andthe infiltrating
cells were recovered by collagenase digestion of the tissue. The cells from untreated (a) or
transfused (b) rats were then used as effectors in a 6-h "Cr-release assay . The Con A blast
target cells in the assay were of three types : LEW, i.e ., blood and kidney donor type ("); DA,
i.e ., recipient type (a) ; or PVG, i.e., third-party type (A) . All E/T ratios were carried out in
duplicate . The results of a single experiment are shown and similar results were obtained in
15 other experiments using the LEW to DA strain combination .A similar degree of specificity
was observed in the lysis of target cells expressing donor alloantigens by effectors from
transfused anduntreated animals in both the DA toPVGand LEWtoPVGstrain combinations
in a total of five experiments .
the unfractionated cell population (67% MRC OX19+) showed 20%, both at an
E/T ratio of 50 :1 .
Discussion
We have demonstrated, using a functional analysis, that 5d after transplanta-
tion the grafted kidneys of blood transfused animals, which survive indefinitely,
contain a high level of T cell-mediated cytotoxic effector activity that has
specificity for kidney donor alloantigens . This activity is present within the
harvested cell population immediately after extraction from the transplanted
organ and therefore should accurately reflect cytotoxicity present within the
graft . Despite the presence of such specific cytotoxicT cells within the transplant,
the grafts of transfused animals are not rejected . There are at least four possible
explanations for this finding . First, although much experimental evidence sup-
ports the notion that the specific cytotoxic cell (defined by its in vitro activity)
plays a critical role in graft rejection, it is possible that cytotoxicity as assayed in
the in vitro system is irrelevant to the rejection process in vivo . Indeed, it may
be argued that the Con A blast is not a suitable target on which to assay a
population of cells that will effect kidney graft rejection . It is difficult, however,
to develop a target that is more appropriate to kidney graft rejection since the
target cell within the kidney whose destruction leads to graft necrosis is not
clearly defined .
Second, it has been suggested that organ graft rejection may be severely
impeded unless MHC class I and 11 antigens are induced on the target tissue
(14) . It is apparent, however, that sufficient target antigens are present within
the transplanted kidney since we have shown, by immunohistology and quanti-
tative absorption, that bothMHC class I and class II antigens are induced equally570
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in the kidney of transfused and untreated recipients (Wood, K. J., M. J. Dallman,
and P.J. Morris, manuscript in preparation).
Third, it is possible that there are qualitative differences in the cytotoxic cells
present in transfused and untreated recipients. Wood and Streilein (15) have
recently demonstrated that qualitative differences may occur in lymphocyte
populations, since cytotoxic cells derived from neonatally tolerant animals may
interact with their target cells with lower avidity than cytotoxic cells from their
normal counterparts. We are currently investigating this possibility.
Finally, it is possible that the action of cytotoxic cells in transfused animals is
blocked within the transplant. Such blocking may occur by the presence of
enhancing antibodies, although other workers (16) have found it difficult to
demonstrate significant levels of such antibody in blood-transfused animals.
Alternatively, it has been suggested that a suppressor cell may block effector
activity. Infiltrating cells with suppressor activity as demonstrated in adoptive
transfer have been isolated from nonrejecting grafts shortlyafter transplantation
(17). However, it seems unlikely that such cells are responsible for inhibiting the
action of cytotoxic cells in the present experiments, as suppressor cells are not
usually effective at blocking fully activated cells, but rather act on the afferent
arm of the immune response (18) . Further, if suppressor cells could block the
effector activity of cytotoxic cells one would not expect to see the high levels of
cytotoxicity so readily demonstrable in the assays reported here. We are currently
examining these alternatives.
These studies demonstrate that the survival of transplanted kidneys in trans-
fused rats cannot be explained by an absence of specific cytotoxic cells within
the recipient, and that the infiltration of specific cytotoxic effector cells into a
transplant does not necessarily result in rejection of that tissue .
Summary
Preoperative, donor-specific blood transfusion leads to indefinite survival of
rat renal allografts in the strain combinations used. "Cr-release assays have
shown that the level of specific cytotoxic effector activity in the grafts of
transfused (nonrejected kidney) animals is very high and may equal or exceed
that seen in the grafts of untreated (rejected kidney) recipients. Such cytotoxicity
demonstrates specificity for the alloantigens of the kidney, is T cell-mediated,
and may persist within the transplant.
We thank Sara Maxwell, Theresa Page, Mary Day, and Michael Pether for technical
assistance and Dr. D. W. Mason for helpful discussions.
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